BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pathophysiol. Nov 15, 2016; 7(4): 300-306
Published online Nov 15, 2016. doi: 10.4291/wjgp.v7.i4.300
Anti-Helicobacter pylori effect of CaG-NANA, a new sialic acid derivative
Yun-Hee Rhee, Hyun-Jeong Ku, Hye-Ji Noh, Hyang-Hyun Cho, Hee-Kyong Kim, Jin-Chul Ahn
Yun-Hee Rhee, Hyun-Jeong Ku, Jin-Chul Ahn, Beckman Laser Institute Korea, Dankook University, Chungnam 31116, South Korea
Hye-Ji Noh, Hyang-Hyun Cho, Hee-Kyong Kim, MEDINUTROL Co., Jeonnam 57024, South Korea
Jin-Chul Ahn, Department of Biomedical Science, College of Medicine, Dankook University, Chungnam 31116, South Korea
Jin-Chul Ahn, Medical Laser Research Center, Dankook University, Chungnam 31116, South Korea
Author contributions: Rhee YH performed the majority of experiments, analyzed the data, and wrote the manuscript; Ku HJ and Noh HJ participated in animal experiments; Cho HH, Kim HK and Ahn JC designed and coordinated the research.
Institutional animal care and use committee statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Dankook University (IACUC protocol number: DKU-14-036).
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Data sharing statement: Statistics and histology analysis of data are available from the corresponding author at jcahn@dankook.ac.kr.
Correspondence to: Jin-Chul Ahn, MD, Department of Biomedical Science, College of Medicine, Dankook University, 119 Dandae-ro, Cheonan, Chungnam 31116, South Korea. jcahn@dankook.ac.kr
Telephone: +82-1899-3700
Received: June 28, 2016
Peer-review started: June 29, 2016
First decision: August 10, 2016
Revised: August 12, 2016
Accepted: September 13, 2016
Article in press: September 18, 2016
Published online: November 15, 2016
Processing time: 138 Days and 2.8 Hours
Core Tip

Core tip: Calcium chelated N-acetylneuraminic acid-glycomacropeptide demonstrates effective anti-bactericidal activity against Helicobacter pylori both in vitro and in vivo.